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Abstract
Background: Nutritional therapy and exercise training (ET) are important interventions for hemodialysis patients.
We investigated the status of nutritional therapy and ET provided at hemodialysis facilities across Japan.
Method: This was a cross-sectional study. The facilities investigated were 3993 facility member institutions of the
Japanese Society for Dialysis Therapy in August 2015. Data was collected on the facility type, number of staff
(doctors, nurses, and medic al engineers), presence of staff (clinical dietitians, pharmacists, and physical therapists),
proportion of elderly patients (age ≥ 65 years), patients with albumin ≤ 3.5 g/dL, and types of oral nutritional
supplements (ONS), intradialytic parenteral nutrition (IDPN), and ET in the facility. We summarized data on facilities
and patient characteristics and calculated the proportion of the nutrition that were ONS, IDPN, and exercise
interventions provided. We used multiple logistic analyses to examine the facility characteristics associated with the
provision of nutritional support and ET.
Results: We obtained responses from 1048 facilities (response rate 26.2%) and 88,492 patients (27.6%). Patients aged ≥
65 years accounted for 63.4% of all investigated patients. Patients with Alb≤ 3.5 g/dL accounted for 37.6% of all
investigated patients. Meals during hemodialysis sessions were provided at 601 facilities (64%), ONS were used at 382
facilities (40%), and IDPN was administered at 471 facilities (46%). Exercise during hemodialysis sessions was provided at
190 facilities (20%). These trends did not change after adjustment of response rates by affiliations of facility type and
region. At the patient level, only a limited number of patients were provided with ONS, IDPN, and ET, 2.1, 2.7, and 3.0%,
respectively. ONS and IDPN were less likely to be offered in hospitals than in clinics without beds (odds ratio (OR) 0.21;
95% confidence interval (CI) 0.09–0.45) (OR 0.37; 95% CI 0.17–0.82). ET was also less likely to be offered in hospitals (OR
0.20; 95% CI 0.08–0.49).
Conclusions: Nutritional support therapy is provided in a considerable number of hemodialysis facilities, ET is increasing
but offered by fewer facilities compared to other countries, while a limited number of patients were provided with ET.
Keywords: Hemodialysis, Questionnaire, Nutritional therapy, Exercise training, National survey
Background
The aging population features prominently among
hemodialysis patients and is influencing the epidemio-
logical characteristics of this patient group. The average
age of incident patients and prevalent patients is more
than 65 years, and the increase in the dialysis population
is currently due to an increase in patients aged 70 years or
more [1]. Protein energy wasting (PEW), frailty, and sarco-
penia are often found in patients with advanced chronic
kidney disease and end-stage kidney disease [2, 3]. These
conditions are reportedly associated with each other.
Moreover, they are related to higher mortality and mor-
bidity [4–6], especially among elderly individuals in whom
physical functions and nutritional status have deteriorated.
Older patients are more vulnerable than younger popula-
tions to further decline in these parameters [2, 7–9].
In the dialysis population, the two primary options to
maintain and even improve nutritional condition and
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physical function are nutritional therapy and exercise
training (ET), provided either within or outside the dialy-
sis facilities. For nutritional therapy, oral nutritional sup-
plements (ONS) given during hemodialysis can be
associated with better survival of dialysis patients [10–13].
In fact, some dialysis facilities offer meals during the ses-
sions [14]. In the USA, dialysis facilities used to restrict
eating during hemodialysis, but in recent years, they have
been shifting toward allowing patients to eat meals [15].
Many studies and meta-analyses have shown that ET im-
proves physical function, muscular strength, and func-
tional capacity [16–18], although the details of how, when,
and to whom ET should be given during hemodialysis ses-
sions remain unclear.
The needs for nutritional therapy and ET in dialysis
facilities are expected to continue to increase, as are the
numbers of patients requiring such treatment. However,
it is not clear how many facilities are offering nutritional
therapy and ET, how many patients are receiving them,
or what the detailed characteristics of these facilities are.
Such information is fundamental and indispensable for
the development of strategic plans for managing older
dialysis patients.
This study sought to clarify the current status of
nutritional therapy and ET interventions provided at
hemodialysis facilities in Japan, in order to identify appro-
priate intervention points and approaches for initiatives at
facilities in the future.
Methods
Study design
This was a cross-sectional study conducted using a
nationwide questionnaire.
Study population
The study was conducted in member institutions of the
Japanese Society for Dialysis Therapy (JSDT). In total, 3993
facilities were registered as member institutions of JSDT as
of August 2015. The survey collected data on the facilities
and patients receiving maintenance hemodialysis in these
facilities during August 2015.
Study protocol
The questionnaire consisted of two parts. The first part
contained questions regarding the facility itself, and the
second part focused on the nutritional support and ET
available at the facility (Additional file 1: Item S1). Ques-
tionnaires were sent to each facility by postal mail. We
asked that completed questionnaires be returned by fax
by the end of October 2015. We also requested that the
conditions of dialysis treatments should not be changed
while answering this questionnaire.
Data collection
The collected data included the following:
1. Facility details
Type: facility types were classified by their affiliation and
size. The classification used by the JSDT annual survey for
affiliations of facilities, i.e., national university hospital, pri-
vate university hospital, national hospital, county municipal-
ities hospital, hospital affiliated to the Japan Community
Healthcare Organization, hospital affiliated to Japan Agricul-
tural Cooperatives, other public hospital, private general
hospital, private hospital, and private clinic. On the other
hand, the original classification of four types according to
their sizes were also investigated, i.e. clinic, clinic with beds,
hospital (< 200 beds), and hospital (≥ 200 beds). The survey
of medical facilities by Ministry of Health Labor and Welfare
Japan determines the size of hospitals by the numbers of
beds in the facility. The hospitals with 200 or more beds are
considered large ones [19].
Region: prefecture and municipality in Japan.
Number of staff: number each of doctors, nurses, and
clinical engineers.
Presence/absence of pharmacist, clinical dietitian, and
physical therapist providing care for patients on dialysis.
Background of treated patients as a whole: number of
patients aged ≥ 65 years, number of patients with
albumin ≤ 3.5 g/dL. We used these cut-off values for the
reasons as follows. Regarding the age, the elderly persons
were defined as having a chronological age of 65 years in
many countries including Japan at the time of this sur-
vey [20], about albumin level, the European Society for
Clinical Nutrition and Metabolism (ESPEN) guideline
described serum albumin < 3.5 g/dL as the criteria for
severe undernutrition for which nutritional therapy is
indicated [21].
2. Intervention provided at hemodialysis facilities: meals,
ONS, intradialytic parenteral nutrition (IDPN), and ET
Statistical analyses
Results are summarized as means and standard deviations
for data showing a normal distribution, and as medians
and interquartile ranges (IQR) for data not showing a
normal distribution. Detailed data are shown as numbers
and percentages.
The following were excluded from analyses as outliers:
facilities where the percentage of aged (≥ 65 years) or
albumin ≤ 3.5 g/dL patients exceeded 100%.
Because the response rates, that is the proportion of
facility that answered the question, differed by facility
type and region, proportions of provision adjusted by
affiliations of facility type and region were calculated as
an average of the stratum-specific proportions weighted
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by their own proportion in the population. We used the
JSDT classification for facility type adjustment and six
districts (Hokkaido and Tohoku, Kanto, Chubu and
Tokai, Kansai, Chugoku and Shikoku, and Kyusyu and
Okinawa) for region adjustment. Differences between
unadjusted and adjusted proportions of interventions
provided were compared by a chi-square test.
Multiple logistic analyses were used to explore the factors
associated with nutritional support and ET offered by the
facility. Dependent variables included the provision of
meals, ONS, IDPN, and ET at each facility. The facility-
related factors investigated were as follows: facility type
(original four types); region (six regions); number of staff
(numbers of doctors, nurses, and clinical engineers)
presented as quartiles; presence of staff (clinical dietitians,
pharmacists, and physical therapists); proportion of elderly
patients (age ≥ 65 years); and proportion of patients with
albumin ≤ 3.5 g/dL. Reference data were set as follows: size
of facility type; clinic without beds, region; Kanto, number
of staff; the first quartile values, and presence/absence of
staff; absence. We also performed a sensitivity analysis in
which per-100-patient staffing level was used instead of
actual number of staff as the covariate. In addition, we
performed inverse probability of censoring weighted
analysis of affiliations of facility type and region specifically
for those facilities that provided responses to all items,
excluding facilities with logically erroneous data for sensi-
tivity analyses to remove the effect of response rate.
First, we performed multivariate analysis with region and
affiliations of facility type as independent variables and
actual response rates of these 60 facility groups. Accordingly,
regression of facility group against response rate was deter-
mined to calculate the response probability of each facility
group. Subsequently, a response probability for each facility
was assigned based on region and affiliations of facility type.
Then, we performed multivariate analysis to investigate
factors affecting each therapy, with the reciprocal of the
response probability included as the weight for each facility.
The proportion of interventions provided was compared
between hemodialysis facility groups with response probabil-
ities dichotomized by the median, using the chi-square test
to investigate the effects of the provision of interventions on
the response probabilities.
We considered p < 0.05 statistically significant. All analyses
were carried out using JMP Pro 11.0 (SAS Institute,
NC, USA).
Ethical issues
The facility name was not specified in the questionnaire.
No data that could identify individual patients were
collected. Return of the completed questionnaire was
deemed as facility consent to participate. This study was
conducted in compliance with the Declaration of Helsinki.
Results
In total, 1048 facilities responded to the questionnaire
(response rate 26.2%). Regarding facility characteristics,
41.3% of facilities were classed as a “clinic without bed” and
31.9% of facilities were located in the Kanto region (Table 1).
The median number of total staff was 18 per facility
(Table 2). In almost half of the facilities, pharmacists and
physical therapists were working, irrespective of affiliation to
the dialysis center, while clinical dietitians were working in
713 facilities (69.6%) (Table 3).
For patient characteristics, data were available regarding
88,492 patients (response rate 27.6%), of which only 9.6%
were hospitalized; the remaining 90.4% were outpatients.
Elderly patients were predominant, with 63.4% of the
patients aged ≥ 65 years. The patients with serum albumin
≤ 3.5 g/dL accounted for 37.6% of all investigated patients.
The median number of patients per facility was 70 (IQR
42–110) (Table 4).
Nutritional and exercise interventions provided
Meals during hemodialysis sessions were provided at 601
facilities (63.9%), ONS were used at 382 facilities (39.8%),
and IDPN was performed at 471 facilities (45.8%). ET
during hemodialysis sessions was provided at 190 facilities
(20.2%). These trends did not change after adjustment by
facility type and region. In contrast, the actual patient
numbers were lower; that is, the proportions of patients
who were offered ONS, IDPN, and ET were 2.1, 2.7, and
3.0%, respectively, of the total patients (Table 5) The
proportions of the interventions provided in the facility
were not associated with the probabilities of response
rates for this survey (Additional file 2: Table S2). This fact
indicated that the interest in providing these interventions
or the interest in responding to this survey might not
affect the actual provision of these therapies.
Table 1 Characteristics of facilities
Number of facilities (%)
Total facilities 1048
Facility type Clinic 430 (41.3)
Clinic with beds 120 (11.5)
Hospital (< 200 beds) 212 (20.4)
Hospital (≥ 200 beds) 279 (26.8)
Unanswered 7
Region Hokkaido, Tohoku 132 (12.8)
Kanto 328 (31.9)
Chubu, Tokai 163 (15.9)
Kansai 169 (16.5)
Chugoku, Shikoku 101 (9.8)
Kyushu, Okinawa 135 (13.1)
Unanswered 20
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Polymeric formula was the type of ONS most frequently
used (56.1%) followed by amino acid formula (31.1%) and
formula for kidney failure patients (19.8%) (Fig. 1). Figure 2
indicates the proportions of patients receiving various
components of IDPN. More than half of the patients
(59.2%) received amino acids only. Most of the patients re-
ceiving IDPN (91.3%) were given amino acids in some
form; the proportion for glucose or lipids in some form
was smaller (29.6 and 17.5%, respectively) (Fig. 2).
The types of ET offered by the facilities were diverse,
including resistance training (RT) and aerobic training
(AT), with each intervention type accounting for almost
one-third of ET. Most patients (81.8%) performed ET
three times per week (Fig. 3).
Regarding exercise duration, almost half (50.2%) of the
patients performed ET for 15–29 min (Fig. 4). More
than half of the facilities that did not offer ET at the time
of the study (61.1%) were considering implementation of
ET in the future.
Characteristic factors in facilities associated with each
therapy
ONS were less likely to be offered in hospitals than in
clinics without beds (p < 0.01). To our surprise, the pres-
ence of a clinical dietitian was not associated with the
use of ONS (p = 0.59). For IDPN, a similar relationship
was observed; the therapy was less likely to be used in
large hospitals than in clinics (p = 0.01). The presence of
pharmacists was not associated with the use of IDPN,
similar to the finding for clinical dietitians for ONS (p =
0.73). ET was also less likely to be offered in hospitals
(p < 0.01) and more likely in clinics with beds (p = 0.03).
The presence of physical therapists was positively associ-
ated with the implementation of ET (p < 0.01).
The facilities with higher proportion of the patients
aged ≥ 65 years were more likely to use ONS and IDPN.
The facilities with higher proportion of the patients with
serum albumin ≤ 3.5 g/dL were more likely to use IDPN,
but ONS showed no significant difference (Table 6). In
the results of the sensitivity analysis, we analyzed the
same factors weighted by the reciprocals of the response
probabilities and obtained similar results as the original
analyses. Moreover, the proportion of the patients with
lower albumin levels was positively associated with the
implementation of ONS (Table 7). Further sensitivity
analysis was conducted using per-100-patient staffing
level and indicated similar results, except that the
number of doctors was negatively associated with the
likelihood of implementation of IDPN and that the
number of clinical engineers was no longer significant
(Additional file 3: Table S3).
Discussion
This is the first nationwide survey concerning the types of
nutritional therapy and ET for patients on hemodialysis in
Table 3 Facilities with and without relevant staff





With staff working in HD 276 (26.9) 495 (48.3) 200 (19.6)
With staff not working in HD 272 (26.5) 218 (21.3) 314 (30.8)
Without staff 478 (46.6) 312 (30.4) 506 (49.6)
HD hemodialysis
Table 2 Number of each type of medical staff per facility and




Number of staff per
number of 10 patients
and facility, median (IQR)
Total staff 18 (12–26) 2.5 (1.9–3.5)
Disciplines Doctor (full-time) 1 (1–3) 0.2 (0.1–0.5)
Doctor (part-
time)
1 (0–4) 0.2 (0–0.5)
Nurse (full-time) 7 (4–11) 1.1 (0.8–1.6)
Nurse (part-time) 1 (0–2) 0.1 (0–0.3)
Clinical engineer
(full-time)
4 (1–6) 0.5 (0.3–0.8)
Clinical engineer
(part-time)
0 (0–0) 0 (0–0)
Table 4 Patient characteristics: breakdown of total patients and








(%, mean ± SD)
Total patients 88,492 70 (42–110)








44 (26–69) (64.3 ± 14.4)
Patients with albumin
≤3.5 g/dL (n = 86,136)
32,331
(37.6)
24 (11–41) (37.6 ± 20.4)
IQR interquartile range, SD standard deviation















Meals 601 (61.1) (63.9) 0.21
ONS 1873 (2.1) 382 (38.9) (39.8) 0.68
IDPN 2425 (2.7) 471 (45.3) (45.8) 0.37
Exercise 2682 (3.0) 190 (19.2) (20.2) 0.57
ONS oral nutritional supplements, IDPN intradialytic parenteral nutrition
Proportion of provision was adjusted for facility type and region
aUnadjusted vs adjusted
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Japan. In this study, we adopted age and serum albumin
as the patients’ characteristics. The proportion of patients
aged ≥ 65 years, which was 63.4% in this study, was almost
identical to that of 61.8% found by JSDT for the entire
Japanese dialysis population [1]. The prevalence of serum
albumin < 3.5 g/dL was slightly greater at 37.5% in the
present study than the 33.8% reported in a JSDT survey
[22], a difference that may be due to the inclusion or ex-
clusion of patients with serum albumin equal to 3.5 g/dL.
Approximately 40% of all facilities were administering
ONS, predominantly the low residue diet that can be
reimbursed by health insurance in Japan and has a well-
balanced nutrient composition. About 50% of all facilities
were offering IDPN. These results were independent of re-
sponse probability. Although the typical composition of
IDPN reported in the literature is a mixture of glucose,
amino acids, and lipid emulsion [23], most facilities in the
present study used only the amino acid formula for IDPN.
This is possibly because the staff focused on the amino acids
removed by the dialysis procedure [24]. Other reasons could
be the higher costs of lipid emulsion compared with amino
acid formula, as well as the time and labor required by med-
ical staff to mix the components for IDPN preparations.
ONS administration may be associated with better
survival [12]. Although IDPN did not have an additive
effect to ONS in malnourished dialyzed patients [25],
IDPN works to facilitate protein anabolism in patients
receiving long-term hemodialysis in the acute phase
[26]. This is evidenced by significant concomitant
increases in lean body mass and albumin synthesis in
the liver [27]. Therefore, both ONS and IDPN can
potentially ameliorate malnutrition. In the present study,
the proportion of patients treated by nutritional therapy
was as small as 2%, while the proportion of patients with
serum albumin ≤ 3.5 g/dL was as high as 37.5%.
Therefore, it is possible that patients who should have
been treated by nutritional therapy did not receive it.
However, hypoalbuminemia is not the sole indication for
nutritional therapy, and this criterion could overestimate
the actual proportion of patients needing nutritional
therapy. Further clarification of the indications for
nutritional therapy is required in actual clinical practice.
A positive point to note, however, is that logistic analysis
showed nutritional therapy is being administered to
patients with low nutrition in some facilities in Japan.
Fig. 1 Types of oral nutritional support. The low residue diet was most commonly used followed by amino acid formula and kidney failure formula.
Oral nutritional supplements (ONS) were offered by 399 facilities; however, this answer included multiple answers so the proportion of each
component was assessed among 523 answers
Fig. 2 Types of intradialytic parenteral nutrition. Proportion of each
component and the mixtures used among the 2425 patients receiving
intradialytic parenteral nutrition (IDPN) are shown. The amino acids
formula alone was the most commonly used (59.0%). Including the
combination of amino acids with glucose or lipid emulsion, 91.3% of
patients received IDPN containing amino acids (black arc with arrows
at both ends). On the other hand, 29.6% of the patients received IDPN
containing glucose (blue scattered arc with arrows), and only 17.5%
received IDPN containing lipids (red arc with arrows). Abbreviations:
AA, amino acids; Glu, glucose; LE, lipid emulsion
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ET was enforced in about 20% of the facilities, and
only 3% of all the patients were receiving ET. Patients
on dialysis have extremely limited exercise capacity
and poor physical functioning [28]. It has been
reported that sedentary behavior in patients on
hemodialysis is associated with an increased risk of
death within 1 year even after adjusting for all covari-
ates [29]. However, ET might increase aerobic
capacity, muscle mass or strength, physical quality of
life, and Kt/V [16, 30]. Additionally, ET during
dialysis therapy is associated with few adverse events
[16, 31, 32]. However, a study from the Dialysis Out-
comes and Practice Patterns Study (DOPPS) showed
that the percentage of units offering exercise
programs was 14% in Japan from 2009 to 2011, while
27 and 37% of the facilities offered ET in Europe or
Australia/New Zealand and in North America,
respectively [33]. This difference between DOPPS and
our study might indicate an increase in the facilities
offering ET over the last few years, as the benefits of
ET have become widely accepted.
ET performed on non-dialysis days is reportedly
the most effective way of training, although difficul-
ties in maintaining adherence have been demon-
strated [34]. In the present study, a limited number
of facilities (up to 20%) provided ET on hemodialysis
days and only 9% provided ET on non-hemodialysis
days. DOPPS showed that the proportion of facilities
providing ET on dialysis and non-dialysis days was
about 10% in japan from 2005 to 2006 [35]. After a
decade, we found the facilities offering the exercise
program on dialysis is increasing as discussed above,
but the facilities offering ET on non-dialysis days
have not increased. Recently it reported that two
daily 10-min walking sessions during the off-dialysis
days (every second day for patients on peritoneal dialysis)
at a prescribed walking speed may improve physical
performance and quality of life [36]. Our findings indicate
that the awareness of ET needs to be further improved.
Each intervention type accounting for almost one-
third of ET. Recently many studies have reported the
evidences about exercise for dialysis patients. But the
Fig. 3 Types and frequency of exercise training. Approximately 30% of patients underwent resistance training (RT) alone, aerobic training (AT) alone, or
RT and AT (A). Further, 82% of patients exercised three times per week (B)
Fig. 4 Exercise duration. Half of the patients underwent exercise for 15–29 min during a single session
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best way to offer ET in dialysis patients remains
unclear. The current study demonstrated that the
actual types of ET were diverse across the facility
offering ET. Many investigations have employed ET as
an intervention for at least 30 min, three times a
week [16]. The duration of ET in Japanese facilities
was found to be shorter in this study, possibly be-
cause the Japanese dialysis population investigated
here was older than that in the reported clinical trials
(aged 40–50 years) [16].
DOPPS reported an important finding: patients who
exercise regularly showed better survival than those who
do not (HR 0.73, 95% CI 0.69–0.78); moreover, patients
who received treatment at a facility with a higher
frequency of exercise also had better survival (HR per
10% increase in regularly exercising patients 0.92, 95%
CI 0.89–0.94) [35]. These results demonstrate that the
practice patterns implemented in a facility could affect
the clinical outcomes of patients treated at that facility.
So it is important for every dialysis facility to be aware
of the usefulness and safety of ET in order to prevent
PEW progression to further unfavorable outcomes. In
fact, over half of the total facilities included in this sur-
vey intended to offer ET.
The present investigation into the background factors
relating to the implementation of these therapies
indicated that clinics tend to offer such therapies rather
than hospitals. In general, clinics without beds manage
larger numbers of chronic patients over longer terms,
enabling them to provide these therapies more fre-
quently than the other facility types. In contrast, we can
consider that the patients in hospitals have different
characteristics from those in clinics; they require the
treatment for acute conditions because the hospitalized
Table 6 Logistic regression analysis
Variable ONS IDPN Exercise
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Clinic 1 reference 1 reference 1 reference
Clinic with beds 0.66 0.38–1.11 0.12 1.15 0.68–1.96 0.60 0.50 0.28–0.95 0.03
Hospital (< 200 beds) 0.49 0.22–1.05 0.07 0.50 0.23–1.10 0.08 0.20 0.08–0.49 < 0.01
Hospital (≥ 200 beds) 0.21 0.09–0.45 < 0.001 0.37 0.17–0.82 0.01 0.08 0.03–0.20 < 0.001
Doctor Q1 1 reference 1 reference 1 reference
Q2 0.95 0.59–1.53 0.83 0.76 0.48–1.21 0.25 0.85 0.46–1.63 0.62
Q3 0.62 0.37–1.05 0.08 0.64 0.38–1.07 0.09 0.97 0.50–1.94 0.94
Q4 0.85 0.50–1.45 0.55 0.86 0.51–1.45 0.56 1.39 0.71–2.79 0.34
Nurse Q1 1 reference 1 reference 1 reference
Q2 1.21 0.81–1.84 0.36 0.83 0.55–1.24 0.36 1.00 0.56–1.79 1.00
Q3 1.71 1.14–2.60 0.01 1.70 1.14–2.56 < 0.01 1.66 0.98–2.83 0.06
Q4 1.64 1.03–2.60 0.04 1.71 1.08–2.70 0.02 1.58 0.90–2.81 0.11
Clinical engineer Q1 1 reference 1 reference 1 reference
Q2 1.17 0.67–2.06 0.58 1.51 0.88–2.63 0.13 1.59 0.73–3.80 0.25
Q3 1.92 1.09–3.44 0.03 2.65 1.51–4.71 < 0.001 1.95 0.88–4.72 0.10
Q4 2.76 1.56–5.00 < 0.001 3.32 1.88–5.95 < 0.001 5.93 2.76–14.03 < 0.001
Presence of pharmacist (vs absence) 0.99 0.54–1.81 0.98 0.90 0.49–1.66 0.73 1.03 0.50–2.07 0.93
Presence of clinical dietitian (vs absence) 1.13 0.73–1.73 0.59 1.01 0.65–1.55 0.97 1.94 1.15–3.29 0.01
Presence of physical therapist (vs absence) 1.84 1.05–3.28 0.03 1.95 1.09–3.55 0.02 3.48 1.85–6.66 < 0.001
Regions Hokkaido/Tohoku 0.79 0.44–1.27 0.29 1.58 0.95–2.64 0.08 2.85 1.48–5.46 < 0.01
Kanto 1 reference 1 reference 1 reference
Chubu/Tokai 1.01 0.63–1.60 0.97 1.62 1.03–2.58 0.04 2.05 1.12–3.73 0.02
Kansai 1.00 0.64–1.56 1.00 1.76 1.13–2.76 0.01 1.98 1.10–3.52 0.02
Chugoku/Shikoku 0.90 0.51–1.57 0.71 1.51 0.87–2.63 0.15 2.03 0.97–4.16 0.06
Kyushu/Okinawa 0.76 0.44–1.30 0.31 0.72 0.42–1.23 0.23 2.69 1.37–5.29 <0.01
Patients aged ≥ 65 years (per 10%) 1.14 1.01–1.28 0.03 1.16 1.03–1.30 0.01 1.07 0.93–1.25 0.35
Patients with albumin ≤ 3.5 g/dL (per 10%) 1.03 0.95–1.12 0.44 1.09 1.01–1.17 0.03 0.95 0.86–1.05 0.35
Abbreviations: OR odds ratio, CI, confidence interval
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patients in other nephrology department tend to have
many comorbidities.
The results obtained from the analyses where staff
number was standardized by patient number confirmed
that IDPN is being predominantly offered in clinics
without beds.
Interestingly, our results indicate that the number of
staff—key elements of each facility—was positively corre-
lated with the implementation of nutritional therapy or
ET. In particular, the results obtained from the analyses
standardized by facility type and region revealed stronger
associations between these factors.
Curiously, the proportions of the older patients or
the patients with lower albumin levels were positively
associated with the implementation of ONS or IDPN.
On the other hand, ET did not have such associations
with the proportions of the patients with such
background. This fact shows the medical director of
the facility might have different criteria to implement
ET from those for ONS and IDPN.
Surprisingly, the provision of ONS or IDPN was
independent of the presence of dietitians or pharmacists in
the facility. This might indicate these therapies might be
readily available irrespective of the professionals available,
although the involvement of dietitians or pharmacists might
improve the quality or effectiveness of these therapies.
There are several limitations to this study. The first is
that this observational study did not examine the data of
individual patients. Therefore, we could not investigate
the detailed relationship between patient characteristics
and the interventions or clinical outcomes. However, the
aim of the study was to investigate the overall status of
these therapies in Japan, which has not been investigated
previously. Second, the response rate for the
Table 7 Logistic regression analysis with inverse probability of response rate weighting for facility type and region
Variable ONS IDPN Exercise
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Clinic 1 reference 1 reference 1 reference
Clinic with beds 0.68 0.52–0.88 < 0.01 1.18 0.96–1.54 0.22 0.56 0.41–0.78 < 0.001
Hospital (< 200 beds) 0.51 0.36–0.73 < 0.001 0.59 0.41–0.85 < 0.01 0.24 0.16–0.37 < 0.001
Hospital (≥ 200 beds) 0.22 0.15–0.33 < 0.001 0.43 029–0.64 < 0.001 0.10 0.06–0.16 < 0.001
Doctor Q1 1 reference 1 reference 1 reference
Q2 0.94 0.74–1.18 0.56 0.89 0.71–1.12 0.33 0.88 0.65–1.20 0.41
Q3 0.59 0.46–0.76 < 0.001 0.66 0.52–0.85 < 0.01 0.88 0.64–1.23 0.46
Q4 0.85 0.66–1.09 0.20 0.84 0.65–1.08 0.18 1.64 1.19–2.30 < 0.01
Nurse Q1 1 reference 1 reference 1 reference
Q2 1.07 0.87–1.30 0.52 0.89 0.73–1.08 0.23 1.14 0.87–1.51 0.34
Q3 1.65 1.35–2.01 < 0.001 1.76 1.45–2.14 < 0.001 1.73 1.34–2.24 < 0.001
Q4 1.62 1.30–2.01 < 0.001 1.69 1.35–2.10 < 0.001 1.70 1.30–2.24 < 0.01
Clinical engineer Q1 1 reference 1 reference 1 reference
Q2 1.10 0.85–1.43 0.47 1.46 1.13–1.89 < 0.01 1.77 1.21–2.65 < 0.01
Q3 1.84 1.41–2.42 < 0.001 2.74 2.10–3.60 < 0.001 1.93 1.30–2.93 < 0.01
Q4 2.66 1.41–3.51 < 0.001 3.36 2.56–4.44 < 0.001 6.36 4.34–9.52 < 0.001
Presence of pharmacist (vs absence) 1.05 0.78–1.41 0.76 0.81 0.60–1.10 0.17 1.04 0.74–1.47 0.80
Presence of clinical dietitian (vs absence) 1.13 0.91–1.40 0.26 1.02 0.82–1.27 0.83 2.05 1.58–2.66 < 0.001
Presence of physical therapist (vs absence) 1.76 1.36–2.29 < 0.001 1.97 1.51–2.59 < 0.001 2.41 1.80–3.25 < 0.001
Regions Hokkaido/Tohoku 0.69 0.54–1.27 < 0.01 1.60 1.24–2.07 < 0.001 2.86 2.06–3.96 < 0.001
Kanto 1 reference 1 reference 1 reference
Chubu/Tokai 0.99 0.72–1.12 0.33 1.52 1.23–1.90 < 0.001 2.33 1.76–3.07 < 0.001
Kansai 1.00 0.80–1.23 0.92 1.53 1.24–1.91 < 0.001 1.77 1.33–2.34 < 0.001
Chugoku/Shikoku 0.71 0.55–0.92 < 0.01 1.35 1.05–1.75 0.02 2.40 1.72–3.33 < 0.001
Kyushu/Okinawa 0.63 0.49–0.81 < 0.001 0.63 0.49–0.81 < 0.001 3.00 2.20–4.09 < 0.001
Patients aged ≥ 65 years (per 10%) 1.13 1.07–1.20 < 0.001 1.22 1.16–1.30 < 0.001 1.04 0.96–1.11 0.34
Patients with albumin ≤3.5 g/dL (per 10%) 1.04 1.00–1.08 0.03 1.09 1.06–1.14 <0.001 0.98 0.93–1.03 0.36
Abbreviations: OR odds ratio, CI confidence interval
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questionnaire was not high 26% of all facilities. Although
detailed patient characteristics were not investigated and
we cannot eliminate the effects of differences in patients
characteristics between responded and non-responded
facilities, the proportions of older patients or the
patients with albumin of 3.5 g/dl or less were not
virtually different from the entire dialysis population in
Japan. On the other hand, the response rate did differ
across the facility types. However, adjustment by affili-
ations of facility type or region yielded no significant
differences in the proportion of facilities offering
these interventions.
Conclusions
Many hemodialysis facilities provided nutritional inter-
vention and for ET are also increasing, while a limited
number of patients provided ET. And the number of
staff was positively correlated with the implementation
of nutritional therapy or ET. We consider it important
to assess the indications for nutritional therapies and ET
for each patient appropriately and to provide patients
with appropriate and detailed knowledge about such
therapies for their proper and wider use. Moreover, the
standardization of nutritional therapy and ET is needed
in the future.
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